- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: Trump to Big Pharma - "We are going to end Global Free-Loading" - BOOM!
Posted on 1/31/17 at 9:59 am to TheTideMustRoll
Posted on 1/31/17 at 9:59 am to TheTideMustRoll
quote:
So, that is the choice we are faced with. Do we socialize healthcare in this country, which would drastically reduce the cost to consumers, but would also negatively impact the quality of healthcare available in not only the US, but in just about every country on earth? Or do we continue to allow the free market to set astronomically high prices, and thereby allow other countries to freeload off the profits companies are able to make here?
Or we stop the cheating by mandating no price lower than drugs are sold anywhere else in the world. #AmericaFirst
0
Posted on 1/31/17 at 9:59 am to therick711
quote:His analogy was so stupid it was laughable.
many people on this Board stuggle with analogies.
In his mind he thought he could explain the difference in drug prices between the U.S. and other countries as a supply and demand issue. It's not. Not even close.
As you linked to in a previous post, it isn't a supply and demand issue. It's a bulk pricing issue based on government bargaining and purchasing leverage.
I don't understand why you're knighting for the guy who completely fricked up with an inapplicable analogy even after you answered my question more plausibly.
Posted on 1/31/17 at 10:00 am to hendersonshands
quote:
Yeah, I know that the FDA has still let shite get through, I guess I just need to see what kind of regulating they plan on doing.
Type 1 and Type 2 errors.. More people die waiting for a drug release than die if the drug is released too soon. Do people really think a reputable drug company wants to kill their customers? If anything, the FDA gives people a false sense of security.
LINK
quote:
In the early 1980s, when I headed the team at the FDA that was reviewing the NDA for recombinant human insulin, . . . we were ready to recommend approval a mere four months after the application was submitted (at a time when the average time for NDA review was more than two and a half years). With quintessential bureaucratic reasoning, my supervisor refused to sign off on the approval—even though he agreed that the data provided compelling evidence of the drug’s safety and effectiveness. “If anything goes wrong,” he argued, “think how bad it will look that we approved the drug so quickly.”
This post was edited on 1/31/17 at 10:02 am
Posted on 1/31/17 at 10:00 am to LSURussian
quote:
As you linked to in a previous post, it isn't a supply and demand issue. It's a bulk pricing issue based on government bargaining and purchasing leverage.
That's supply and demand, bro. I'm not knighting for anyone, I'm just trying to move the discussion forward. Your ego play doesn't really concern me. Just trying to answer the questions put forward. I'm ready to collect my one Russian hurt feelings downvote.
This post was edited on 1/31/17 at 10:01 am
Posted on 1/31/17 at 10:01 am to therick711
quote:No, it's not,.........bro.
That's supply and demand, bro.
Posted on 1/31/17 at 10:01 am to LSURussian
Sure it isn't.
Posted on 1/31/17 at 10:02 am to tigereye58
quote:Then maybe we shouldn't gut the FDA's budget. Also, the FDA reviews drug trials as they move through completion. They go out of their way to help new drugs get on the market.
Regulation of better clinical data isn't bad but the FDA taking 10 months to review a drug application is pathetic.
Also, dying patients can get any drug they want, it is just that the drug companies can't make a profit off of them. Otherwise you would have a lot of "snake oil" on the market. Do you really want that?
Posted on 1/31/17 at 10:04 am to therick711
quote:How so? The supply is in Europe. The demand is here.
That's supply and demand, bro.
Posted on 1/31/17 at 10:07 am to NC_Tigah
quote:
How so? The supply is in Europe. The demand is here.
He's discussing a different issue, namely why foreign markets have better pricing. He's confusing quantity demanded with the demand relationship.
Posted on 1/31/17 at 10:08 am to mmcgrath
quote:Well that obviously isn't true.
Also, dying patients can get any drug they want
But the larger point is the FDA has actually improved efficiencies over the past decade or so. It results in a far lesser differential vs Europe (for example) than it did in the past. The major market differential along those lines is legal risk.
Posted on 1/31/17 at 10:09 am to NC_Tigah
He apparently flunked Econ 1001, NC.
What's so funny is he linked to the most plausible explanation and yet he's arguing supply and demand is the answer. That tells me he didn't comprehend the meaning of what he linked.
If foreign governments can negotiate prices lower then good for them.
But the question remains, is the US consumer footing the entire cost of R&D?
If so, if we negotiate down the cost of prescription drugs here to the level of Europe and Canada, will that cause pharma companies to cut back on R&D?
What's so funny is he linked to the most plausible explanation and yet he's arguing supply and demand is the answer. That tells me he didn't comprehend the meaning of what he linked.
If foreign governments can negotiate prices lower then good for them.
But the question remains, is the US consumer footing the entire cost of R&D?
If so, if we negotiate down the cost of prescription drugs here to the level of Europe and Canada, will that cause pharma companies to cut back on R&D?
Posted on 1/31/17 at 10:11 am to therick711
quote:No.
He's discussing a different issue, namely why foreign markets have better pricing
It's the identical issue.
Again, supply and demand is only apropos if supply is in contact with demand.
That is not the case in this situation.
This post was edited on 1/31/17 at 10:12 am
Posted on 1/31/17 at 10:11 am to LSURussian
I'm sorry discussing the issues rationally hurt your feelings. I didn't mean to insult you. 
Posted on 1/31/17 at 10:13 am to NC_Tigah
quote:
Again supply and demand is only apropos if supply is in contact with demand.
No, I get what you are saying. I'm not arguing that. I'm not arguing it is a free market. I'm arguing that one customer acting on behalf of large quantity demanded has a lot of power in the transaction. That's a demand issue. The loss of contact causes the externalities that pharma handles by leveraging the US market. It's a good point and one that there are a few ways to counteract.
Posted on 1/31/17 at 10:13 am to NC_Tigah
quote:
Perhaps the conundrum is less obvious to you than it should be?
Demonstrating the issue through an extreme example is a normal part of any argument. Perhaps you're new to rational arguments.
Posted on 1/31/17 at 10:14 am to therick711
You're the one melting worrying about down( ) or up votes. Silliness personified.
It's plain you're clueless about what "supply and demand" means.
) or up votes. Silliness personified. It's plain you're clueless about what "supply and demand" means.
quote:You didn't insult me other than to waste my time.....
I didn't mean to insult you.
Posted on 1/31/17 at 10:14 am to LSURussian
Again, I sincerely apologize for hurting your feelings. Have a good one.
Posted on 1/31/17 at 10:16 am to NC_Tigah
quote:This is the biggest line of BS that shows Trump is either clueless or is lying.
One thing that has always disturbed me, they come up with a new drug for a patient who is terminal and the FDA says, 'we can't have this drug used on the patient.'
But they say that the patient within four weeks will be dead. They say, 'Well, we still can't approve the drug. And we don't know if the drug works or if it doesn't work, but we can't approve the drug because we don't want to hurt the patient.' But the patient is not gonna live more than four weeks!
This post was edited on 1/31/17 at 10:18 am
Posted on 1/31/17 at 10:16 am to AUbagman
quote:
Type 1 and Type 2 errors.. More people die waiting for a drug release than die if the drug is released too soon. Do people really think a reputable drug company wants to kill their customers? If anything, the FDA gives people a false sense of security.
Do people understand that big Pharma has been driving these "dying patients access to experimental treatments" through state legislature after state legislature?
Why?
I sat in the Missouri legislature across the aisle from a whole slew of blue suited lobbyists and experts for big Pharma. They were ecstatic about it.
Posted on 1/31/17 at 10:17 am to therick711
quote:
I'm arguing that one customer acting on behalf of large quantity demanded has a lot of power in the transaction. That's a demand issue.
So the greater demand in Europe via governmental buying power causes prices there to go DOWN?!?
You've got it completely backwards, if that's your argument.
Page 6 of 10
Popular
Back to top
Follow TigerDroppings for LSU Football News